(4S,5S)-1,3,4,5-tetraphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 98%, 1g

(2R,4S)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate, 95.0%, 1g

Methyl 2-amino-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 1g

(3-phenyl-1H-pyrazol-1-yl)acetic acid, 95.0%, 1g

Fmoc-Val-Cit-PAB, 5g

(S)-(-)-Glycidol>96.0%(GC)25g

Ethyl 1-hydroxycyclohexanecarboxylate, 95.0%, 10g

Methyl 5-bromo-2-thiophenecarboxylate, 95.0%, 5g

TRIFLUOROMETHANESULFONIC ACID OXETAN-3-YL ESTER, 95.0%, 250mg

Methyl 3-(bromomethyl)-4-chlorobenzoate, 97.0%, 250mg

(4S,4'S,5S,5'S)-2,2'-(1-METHYLETHYLIDENE)BIS(4,5-DIHYDRO-4,5-DIPHENYLOXAZOLE), 95%, 250mg

(2R,4R)-Methyl 2-methylpiperidine-4-carboxylate hydrochloride, 97%, 5g

(1S)-1-cyclopropyl-2,2,2-trifluoroethan-1-amine hydrochloride, 95.0%, 1g